Lung Cancer News and Research

Latest Lung Cancer News and Research

GTx reports revenue of $1.6 million for second quarter 2012

GTx reports revenue of $1.6 million for second quarter 2012

Clovis Oncology reports net loss of $15.7 million for second quarter 2012

Clovis Oncology reports net loss of $15.7 million for second quarter 2012

Older men with higher levels of free testosterone more likely to develop prostate cancer

Older men with higher levels of free testosterone more likely to develop prostate cancer

Gut microbiota drive metabolic changes in pregnancy

Gut microbiota drive metabolic changes in pregnancy

Less is definitely more for men who undergo nephrectomy

Less is definitely more for men who undergo nephrectomy

Adiposity linked to cognitive decline in elderly

Adiposity linked to cognitive decline in elderly

CPRIT awards $48.2 million in new grants to investigators at UT Southwestern Medical Center

CPRIT awards $48.2 million in new grants to investigators at UT Southwestern Medical Center

Empa physicist analyzes structure and composition of soot particles

Empa physicist analyzes structure and composition of soot particles

Rexahn announces completion of RX-3117 exploratory Phase I clinical trial in cancer patients

Rexahn announces completion of RX-3117 exploratory Phase I clinical trial in cancer patients

Neutrophils play an unexpected role in mediating insulin resistance

Neutrophils play an unexpected role in mediating insulin resistance

Diabetes impairs women’s sex life

Diabetes impairs women’s sex life

Six hospitals join CoC ProvenCare Lung Cancer Collaborative

Six hospitals join CoC ProvenCare Lung Cancer Collaborative

Serving size in the eye of the beholder

Serving size in the eye of the beholder

Breast cancer drug bevacizumab (Avastin): an interview with Dr Anna Dorothea Wagner

Breast cancer drug bevacizumab (Avastin): an interview with Dr Anna Dorothea Wagner

Life Technologies second quarter revenue increases 1% to $950 million

Life Technologies second quarter revenue increases 1% to $950 million

E-nose detects malignant mesothelioma

E-nose detects malignant mesothelioma

EPHA3 mutations may be important drivers of lung cancers

EPHA3 mutations may be important drivers of lung cancers

Conception plans miscarry with sperm DNA damage

Conception plans miscarry with sperm DNA damage

Antioxidants and pancreatic cancer risk: an interview with Dr Andrew Hart

Antioxidants and pancreatic cancer risk: an interview with Dr Andrew Hart

ARIAD Pharmaceuticals commences ponatinib Phase 3 trial in newly diagnosed CML

ARIAD Pharmaceuticals commences ponatinib Phase 3 trial in newly diagnosed CML

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.